Enzo Biochem Inc/ US2941001024 /
| 2024-04-26 9:59:42 PM | Chg. -0.03 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 1.06USD | -2.75% | 2,228 Turnover: 2,334.73 |
-Bid Size: - | -Ask Size: - | 53.79 mill.USD | - | 2.56 |
Assets
| 2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 8.6000 | 7.7300 | 7.9480 | 8.2140 | 7.9010 | ||||||
| Intangible Assets | 9.9000 | 8.1080 | 6.1550 | 4.4220 | 2.8950 | ||||||
| Long-Term Investments | - | - | - | - | - | ||||||
| Fixed Assets | - | 23.6750 | 21.9080 | 20.4240 | 18.5810 | ||||||
| Inventories | 8.8000 | 8.6900 | 7.3960 | 6.9710 | 7.0470 | ||||||
| Accounts Receivable | 12.3000 | 12.4700 | 12.1090 | 14.5920 | 15.1800 | ||||||
| Cash and Cash Equivalents | 9 | 17.4550 | 18.1090 | 67.7770 | 64.1670 | ||||||
| Current Assets | 32.6000 | 40.7360 | 46.4860 | 91.3970 | 89.0840 | ||||||
| Total Assets | 59 | 64.4110 | 68.3940 | 111.8210 | 107.6650 | ||||||
Liabilities
| 2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 8.5000 | 8.2450 | 8.7620 | 9.8570 | 10.3500 | ||||||
| Long-term debt | - | - | - | - | - | ||||||
| Liabilities to Banks | - | - | - | - | - | ||||||
| Provisions | 12 | 13.1000 | 11.3400 | 8.2000 | 6.7000 | ||||||
| Liabilities | 24.8000 | 27.4610 | 25.7880 | 22.2670 | 18.7930 | ||||||
| Share Capital | .4000 | .4430 | .4610 | .4630 | - | ||||||
| Total Equity | 34.1000 | 36.9500 | 42.6060 | 89.5540 | 88.8720 | ||||||
| Minority Interests | - | - | - | - | - | ||||||
| Total liabilities equity | 59 | 64.4110 | 68.3940 | 111.8210 | 107.6650 | ||||||
Income Statement
| 2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 93.7000 | 95.9470 | 97.5990 | 102.7730 | 107.8040 | ||||||
| Depreciation (total) | - | 3.9710 | 3.7890 | 3.8400 | 3.5980 | ||||||
| Operating Result | -19 | -10.1800 | -1.2060 | 47.0030 | -3.0660 | ||||||
| Interest Income | -.0500 | -.2080 | -.2450 | -.1360 | .3840 | ||||||
| Income Before Taxes | -18.9000 | -9.9050 | -2.2920 | 46.5150 | -2.4220 | ||||||
| Income Taxes | -.7000 | .0720 | -.0070 | 1.2290 | .0820 | ||||||
| Minority Interests Profit | - | - | - | - | - | ||||||
| Net Income | -18.2000 | -9.9770 | -2.2850 | 45.2860 | -2.5040 | ||||||
Per Share
Cash Flow
| 2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | -10 | -1.6970 | -3.7000 | 53.1260 | -.2050 | ||||||
| Cash Flow from Investing Activities | -1 | -.8330 | -1.7520 | -1.5120 | -1.7490 | ||||||
| Cash Flow from Financing | 4.8000 | 10.9170 | 6.2250 | -1.9310 | -1.6690 | ||||||
| Decrease / Increase in Cash | -6.1000 | 8.4480 | .6540 | 49.6680 | -3.6100 | ||||||
| Employees | 423 | 475 | 483 | 489 | 472 | ||||||
